Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
04/2003
04/02/2003EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296935A1 Process for the preparation of substituted octanoyl amides
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1296716A2 New formulation
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP1257534A4 Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0948964B1 Novel n-substituted pyrrolidine derivatives and process for preparing the same
04/02/2003EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders
04/02/2003EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
04/02/2003EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1407966A Optically active materials
04/02/2003CN1407061A Optical aligning material for liquid crystal alignment membrane
04/02/2003CN1104415C Process for preparing 2-phenyl-3-naphthylpropionic acid derivs
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104239C Novel N-substitued pyrrolidine derivatives and process for preparing same
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction
04/01/2003US6541635 Silylprotected L-proline derivative or salt is deprotected in presence of a nonaqueous medium containing an organic solvent at a temperature of 5 degree C. to 40 degree C.
04/01/2003US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium
04/01/2003US6541491 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
04/01/2003US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
04/01/2003US6541473 Resorcinol derivatives
04/01/2003US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist
04/01/2003US6540793 Coupler for use in oxidative hair dyeing
03/2003
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor
03/27/2003WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024327A1 Magnetic resonance imaging method, apparatus, and rf reception coil apparatus
03/27/2003WO2003024220A1 Delta 1-pyrrolines used as pesticides
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2002101007A3 Antipathogenic benzamide compounds
03/27/2003WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/27/2003WO2002090299A3 Method for the production of a purified melt of at least one monomer
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/27/2003US20030060531 Do not require solvent to provide a system having suitable viscosity for convenient handling; rapid cure; adhesively attaching a microelectronic device to a substrate; die-attach paste
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030059785 Detection of markers in nascent proteins
03/27/2003US20030056788 Partial liquid breathing of fluorocarbons
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003CA2460125A1 Novel compounds and compositions as cathepsin inhibitors
03/26/2003EP1295876A1 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295872A1 Drug composition antagonistic to both pgd 2?/txa 2? receptors
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/26/2003EP0986585B1 Use of ylides of phosphorus as slightly nuceophilic strong bases
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1405153A 15N-L-proline separating and purifying method
03/25/2003US6538139 Preparation of pyrrole and pyridine
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6537995 Heterocyclic carboxamides
03/20/2003WO2003022811A1 Method for the production of 2-pyrrolidone
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003004457A3 Preparation process for atorvastatin and intermediates
03/20/2003WO2003004455A3 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002058635A3 Nicotine immunogens and antibodies and uses thereof
03/20/2003US20030055297 Process for the preparation of substituted pyrrolidine neuraminidase inhibitors
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055094 Bicyclic modulators of androgen receptor function
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055045 Novel compounds with analgesic effect
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003US20030055002 For cancer therapy
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/19/2003EP1293500A2 Method for preparation of acrylonitrile solutions of maleimides
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003EP0871490B1 Branched hydrazone linkers
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403157A Method for treating female sexual dysfunction and evaluating compound for treating female sexual dysfunction
03/18/2003WO2002024637A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
03/18/2003US6534657 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions
03/18/2003US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 404